MedTrace Logo

Standardisation of Investigations of Mild Bleeding Disorders

NCT02329899 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 208

Last updated 2016-11-04

No results posted yet for this study

Summary

Observational study aimed at evaluating the clinical impact of a standardised diagnostic procedure for the investigation of patients with suspected mild bleeding disorder (MBD).

Conditions

  • Hemorrhagic Disorders

Interventions

OTHER

Second step of investigations

Second step according to results of the first step: * exploration of coagulation factors; * factor XIII and fibrinolysis investigations; * investigation of platelet function; * investigation of thrombocytopenia.

Sponsors & Collaborators

  • University Hospital, Geneva

    lead OTHER

Principal Investigators

  • Boehlen Francoise, MD · Haemostasis unit, University Hospitals of Geneva, Switerland

Eligibility

Min Age
2 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2016-09-30
Completion
2016-09-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02329899 on ClinicalTrials.gov